Posted by Michael Wonder on 21 Sep 2022
The on- and off-ramps of oncology accelerated approval
21 September 2022 - To address ongoing concerns about the implementation of the FDA’s accelerated approval pathway in oncology, a comprehensive strategy is needed — one that equally emphasises “on-ramp” and “off-ramp” considerations.
